期刊文献+

来曲唑联合替西罗莫司作为一线内分泌治疗绝经后晚期乳腺癌的随机Ⅲ期安慰剂对照研究 被引量:28

Randomized Phase Ⅲ Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus as First-Line Endocrine Therapy in Postmenopausal Women with Locally Advanced or Metastatic Breast Cancer
下载PDF
导出
摘要 1文献来源Wolff AC,Lazar AA,Bondarenko I,et al.Randomized phase Ⅲ placebo-controlled trial of Letrozole plus oral Temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer[J].J Clin Oncol,2013,31(2):195-202.2证据水平1a。 <正>1文献来源Wolff AC,Lazar AA,Bondarenko I,et al.Randomized phase Ⅲ placebo-controlled trial of Letrozole plus oral Temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer[J].J Clin Oncol,2013,31(2):195-202.2证据水平1a。
出处 《循证医学》 CSCD 2013年第3期135-137,共3页 The Journal of Evidence-Based Medicine
关键词 转移性乳腺癌 替西罗莫司 临床试验 Ⅲ期 metastatic breast cancer Temsirolimus clinical trial, phase Ⅲ
  • 相关文献

同被引文献74

引证文献28

二级引证文献132

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部